Navigation Links
Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Date:5/1/2012

ted income per common share$1.75To$1.95Upfront and milestone-related payments to partners

$0.71$0.71Amortization of commercial intangible assets and inventory step-up

$1.87$1.87Acquisition and integration costs related to recent acquisitions.

$0.29$0.29One-time payment now expected to be made to Impax Labs

$0.90$0.90Impairment of long-lived assets

$0.33$0.33Interest expense adjustment for ASC 470-20 and other treasury related items

$0.21$0.21Tax effect of pre-tax adjustments at the applicable tax rates and certain other expected cash tax savings as a result of recent acquisitions

($1.06)($1.06)Diluted adjusted income per common share guidance $5.00To$5.20The company's guidance is being issued based on certain assumptions including:

  • Certain of the above amounts are based on estimates and there can be no assurance that Endo will achieve these results.
  • Includes all completed business development transactions as of May 1, 2012.
  •  About Endo Endo Pharmaceuticals Holdings Inc. (Endo) is a US-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology. Through our operating companies: AMS, Endo Pharmaceuticals, HealthTronics and Qualitest, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates maximum value for patients, providers and payers alike. Learn more at www.endo.com.(Tables Attached)The following tables present Endo's unaudited Net Revenues for the three months ended March 31, 2012 and 2011: Endo Pharmaceuticals Holdings Inc.Net Revenues (unaudited)(in thousands) Three Months Ended

     March 312012

    2011

    Percent

    GrowthEndo PharmaceuticalsLIDODERM®$  210,014
    '/>"/>

    SOURCE Endo
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Hospira Reports First-Quarter 2012 Results
    2. Luminex Corporation Reports First Quarter 2012 Results
    3. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    4. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    10. Cepheid Reports 2012 First Quarter Results
    11. Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/21/2014)... Israel , July 21, 2014 ... "Integrity"), developer of the GlucoTrack ® model ... that it has entered, through its wholly-owned subsidiary, ... Wistron Corp, the manufacturing arm of Acer Inc.  ... manufacture and service (on a non-exclusive basis) the ...
    (Date:7/21/2014)... JOLLA, Calif. , July 21, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that the U.S. Food & Drug Administration (FDA) ... single stranded, chemically modified oligonucleotide that binds to ... a therapeutic for the treatment of Alport syndrome, ...
    (Date:7/21/2014)... DIEGO , July 21, 2014  An International ... a redesign of its iCH CPAP device, Taiwanese device ... humidification. ResMed (NYSE: RMD ) is the ... for the treatment of sleep-disordered breathing. ... improving designs to reach new levels of comfort, performance ...
    Breaking Medicine Technology:Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2
    ... OSLO, Norway, October 31, 2011 Oslo ... oncology. The true strength of the Norwegian cluster lies ... than the ones available to cancer patients today. ... cluster within the field of oncology, dedicated to accelerating ...
    ... Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and ... (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee ... 01 Blood Glucose Meters as the first and second ... of service as noted by the Uniform Formulary Beneficiary ...
    Cached Medicine Technology:Expanding Norwegian Cluster of Excellence Dedicated to Oncology 2Expanding Norwegian Cluster of Excellence Dedicated to Oncology 3ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary. 2
    (Date:7/22/2014)... 2014 Bramal LED announced that they will ... Begley Jr, airing later this year via Discovery Channel. Dates ... learn about Bramal LED’s T-10 lamps, which provide over 80,000 ... up to 70 percent. Bramal LED’s T-10 lamps can be ... seconds or on direct AC voltage, with no need for ...
    (Date:7/22/2014)... 2014 Chris Carpenter’s Info Cash ... takes a comprehensive, step-by-step approach to teaching the techniques ... has just been released to the public, prompting a ... marketing world if you’re unable to generate traffic you’re ... people simply give up when they find traffic generation ...
    (Date:7/22/2014)... NY (PRWEB) July 22, 2014 BlackBox ... Blast Gauge™ System with advancements including a ... The new gauges represent a functional revision of the ... capability to capture complex data on blast events by ... resulting accelerations. The extreme changes in overpressure that accompany ...
    (Date:7/22/2014)... BESLER Consulting, a leading provider of ... is pleased to offer a complimentary version of ... hospitals with analyzing their 2015 QualityNet Hospital-Specific Reports ... 21 allow hospitals to validate their Medicare readmissions ... data contained in these reports can be cumbersome ...
    (Date:7/22/2014)... One woman who looked at diet pills ... pounds. Unfortunately, the weight loss came at a price – ... her time using the pill, and says her personality changed ... insomnia as a result of the caffeine content of one ... age of 37 because of a diet pill she was ...
    Breaking Medicine News(10 mins):Health News:Bramal LED to be featured in Upcoming Episode of Innovations with Ed Begley, Jr. 2Health News:Info Cash 2.0: Review Of Chris Carpenter’s Online Marketing Training Released 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 3Health News:Complimentary Re-admissions Analytics Tool Available From BESLER Consulting 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2
    ... Mercedes Walton, CEO of Cryo-Cell International, one of the ... progress to date and encouraging continued momentum for existing bills through ... Cord Blood Banking Act," and H.R. 2107, the "Cord Blood Education ... progress from the first half of the year to enable and ...
    ... Sociological Association,s 104th annual meeting, will be the subject ... present research and explore the politics, history, health and ... More than 5,000 sociologists will convene in the ... New Politics of Community," the meeting,s theme. In addition ...
    ... , SAN DIEGO, July 6 ADVENTRX Pharmaceuticals, Inc. ... it has completed the previously announced sale of shares ... to a registered direct offering to a single institutional ... percent, or approximately $340,250, of the gross proceeds will ...
    ... showed muscle fiber damage even after halting drugs, researchers say ... used to lower cholesterol, may cause structural damage to the ... study has found. , The damage may occur even when ... and may persist even after statin use is halted, according ...
    ... Eli Lilly and Company (NYSE: LLY ) will ... Wednesday, July 22, 2009. Lilly will also conduct a conference ... further detail the company,s financial performance. , , The ... EDT. Investors, media and the general public can access a ...
    ... Inc. (Nasdaq: SLTM ), a global leader in ... an amendment with Silicon Valley Bank, a member company of ... the company,s credit facility has been expanded from $9 million ... the secured revolving loan facility to $8.0 million, an amendment ...
    Cached Medicine News:Health News:Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood 2Health News:Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood 3Health News:Sociologists to turn the sociological eye on San Francisco 2Health News:ADVENTRX Pharmaceuticals Announces Closing of Financing 2Health News:ADVENTRX Pharmaceuticals Announces Closing of Financing 3Health News:ADVENTRX Pharmaceuticals Announces Closing of Financing 4Health News:Statins May Cause Muscle Damage in Some Patients 2Health News:Statins May Cause Muscle Damage in Some Patients 3Health News:Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 2Health News:Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 3
    ... Shepard Clear Corneal Diamond Knife is a ... Dennis Shepard of Santa Maria, California. This ... Shepard's need for a quality instrument that ... Corneal Surgical technique. Through professional collaboration between ...
    The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology....
    ... Software is a new approach to practice management, ... face in todays healthcare market. OPIE was created ... who work exclusively in this field, so it ... functional and easy-to-use than anything else available. If ...
    ... The DioLite 532 laser is ... and pigmented skin lesions such as ... port wine stains, lentigines, dermatosis papulosis ... technology offers unsurpassed reliability, a selection ...
    Medicine Products: